Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gwladys Temkou Ngoupaye, Makwena Mokgokong, Thobeka Madlala & Musa Vuyisile Mabandla. (2023) Alteration of the α5 GABA receptor and 5HTT lead to cognitive deficits associated with major depressive-like behaviors in a 14-day combined stress rat model. International Journal of Neuroscience 133:9, pages 959-976.
Read now
Read now
Andrea Schmitt, Dan Rujescu, Micha Gawlik, Alkomiet Hasan, Kenji Hashimoto, Sylvain Iceta, Marek Jarema, Joseph Kambeitz, Siegfried Kasper, Daniel Keeser, Johannes Kornhuber, Nikolaos Koutsouleris, Rupert Lanzenberger, Berend Malchow, Mohamed Saoud, Marie Spies, Gerald Stöber, Florence Thibaut, Peter Riederer & Peter Falkai. (2016) Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics. The World Journal of Biological Psychiatry 17:6, pages 406-428.
Read now
Read now
S Kasper. (2002) Sertindole: safety and tolerability profile. International Journal of Psychiatry in Clinical Practice 6:1, pages 27-32.
Read now
Read now
Articles from other publishers (67)
Rita Indirli, Valeria Lanzi, Maura Arosio, Giovanna Mantovani & Emanuele Ferrante. (2023) The association of hypogonadism with depression and its treatments. Frontiers in Endocrinology 14.
Crossref
Crossref
Neelam Kumari, Ankur Kaul, Raunak Varshney, Vinay Kumar Singh, Krishna Srivastava, Sunita Bhagat, Anil Kumar Mishra & Anjani Kumar Tiwari. (2021) Synthesis and evaluation of technetium-99m labelled 1-(2-methoxyphenyl)piperazine derivative for single photon emission computed tomography imaging for targeting 5-HT1A. Bioorganic Chemistry 111, pages 104972.
Crossref
Crossref
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Crossref
Roberto Colangeli, G. Campbell Teskey & Giuseppe Di Giovanni. 2021. 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part A. 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part A
83
134
.
Aren van Waarde, Kurt Audenaert, Geraldo F. Busatto, Carlos Buchpiguel & Rudi A. J. O. Dierckx. 2021. PET and SPECT in Psychiatry. PET and SPECT in Psychiatry
741
772
.
Li Duan, Yunfeng Gao, Xiaojun Shao, ChunSheng Tian, Chunfeng Fu & Gang Zhu. (2020) Research on the Development of Theme Trends and Changes of Knowledge Structures of Drug Therapy Studies on Major Depressive Disorder Since the 21st Century: A Bibliometric Analysis. Frontiers in Psychiatry 11.
Crossref
Crossref
So Hyeon Park, Yoo Sung Song, Byung Seok Moon, Byung Chul Lee, Hyun Soo Park & Sang Eun Kim. (2019)
Combination of
In Vivo
[
123
I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
. Experimental Neurobiology 28:5, pages 602-611.
Crossref
Crossref
Nina Dedic, Philip G. Jones, Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy & Kenneth S. Koblan. (2019)
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D
2
Receptor Mechanism of Action
. Journal of Pharmacology and Experimental Therapeutics 371:1, pages 1-14.
Crossref
Crossref
Amine Bahi & Jean-Luc Dreyer. (2019) Dopamine transporter (DAT) knockdown in the nucleus accumbens improves anxiety- and depression-related behaviors in adult mice. Behavioural Brain Research 359, pages 104-115.
Crossref
Crossref
Wei Zheng, Xiao-Hong Li, Dong-Bin Cai, Xin-Hu Yang, Gabor S. Ungvari, Chee H. Ng, Yu-Ping Ning & Yu-Tao Xiang. (2018) Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. European Neuropsychopharmacology 28:1, pages 149-158.
Crossref
Crossref
Xuefei Huang, Jing Yang, Sijin Yang, Shousong Cao, Dalian Qin, Ya Zhou, Xiaoli Li, Yun Ye & Jianming Wu. (2017) Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms. Oncotarget 8:60, pages 102705-102720.
Crossref
Crossref
Markus Dold, Gernot Fugger, Martin Aigner, Rupert Lanzenberger & Siegfried Kasper. (2015) Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials. Schizophrenia Research 166:1-3, pages 187-193.
Crossref
Crossref
Aren van Waarde, Kurt Audenaert, Geraldo F. Busatto, Carlos Buchpiguel & Rudi A. J. O. Dierckx. 2014. PET and SPECT in Psychiatry. PET and SPECT in Psychiatry
555
581
.
Pau Celada, Analía Bortolozzi & Francesc Artigas. (2013) Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research. CNS Drugs 27:9, pages 703-716.
Crossref
Crossref
Peter Höfer, Rupert Lanzenberger & Siegfried Kasper. (2013) Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacology. European Neuropsychopharmacology 23:2, pages 79-88.
Crossref
Crossref
Yuejun Huang, Hongwu Xu, Hui Li, Hanhua Yang, Yunbin Chen & Xuechuan Shi. (2012) Pre-gestational stress reduces the ratio of 5-HIAA to 5-HT and the expression of 5-HT1A receptor and serotonin transporter in the brain of foetal rat. BMC Neuroscience 13:1.
Crossref
Crossref
Christoph Kraus, Andreas Hahn, Markus Savli, Georg S. Kranz, Pia Baldinger, Anna Höflich, Christoph Spindelegger, Johanna Ungersboeck, Daniela Haeusler, Markus Mitterhauser, Christian Windischberger, Wolfgang Wadsak, Siegfried Kasper & Rupert Lanzenberger. (2012) Serotonin-1A receptor binding is positively associated with gray matter volume — A multimodal neuroimaging study combining PET and structural MRI. NeuroImage 63:3, pages 1091-1098.
Crossref
Crossref
Masakuni Horiguchi, Kayleen E Hannaway, Adesewa E Adelekun, Karu Jayathilake & Herbert Y Meltzer. (2012) Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist. Neuropsychopharmacology 37:10, pages 2175-2183.
Crossref
Crossref
M. Horiguchi & H. Y. Meltzer. (2012) The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats. Psychopharmacology 221:2, pages 205-215.
Crossref
Crossref
Anastasia Diamantopoulou, Androniki Raftogianni, Antonios Stamatakis, Filaretos Alikaridis, Melly S. Oitzl & Fotini Stylianopoulou. (2012) Denial of Reward in the Neonate Shapes Sociability and Serotonergic Activity in the Adult Rat. PLoS ONE 7:3, pages e33793.
Crossref
Crossref
N. Pavese, B.S. Simpson, V. Metta, A. Ramlackhansingh, K. Ray Chaudhuri & D.J. Brooks. (2012) [18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease. NeuroImage 59:2, pages 1080-1084.
Crossref
Crossref
Herbert Y. Meltzer, Masakuni Horiguchi & Bill W. Massey. (2011) The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology 213:2-3, pages 289-305.
Crossref
Crossref
Matthew S. Milak, Christine DeLorenzo, Francesca Zanderigo, Jaya Prabhakaran, J.S. Dileep Kumar, Vattoly J. Majo, J. John Mann & Ramin V. Parsey. (2010)
In Vivo
Quantification of Human Serotonin 1A Receptor Using
11
C-CUMI-101, an Agonist PET Radiotracer
. Journal of Nuclear Medicine 51:12, pages 1892-1900.
Crossref
Crossref
Tomiki Sumiyoshi, Masahiko Tsunoda, Yuko Higuchi, Toru Itoh, Tomonori Seo, Hiroko Itoh, Michio Suzuki & Masayoshi Kurachi. (2010) Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia. Advances in Therapy 27:5, pages 307-313.
Crossref
Crossref
Neal R. Cutler, John J. Sramek, Michael F. Murphy, Henry RiordanSrSr, Peter Bieck & Angelico Carta. 2010. Critical Pathways to Success in CNS Drug Development. Critical Pathways to Success in CNS Drug Development
101
166
.
Kasper Siegfried. (2010) Brain imaging as a diagnostic tool in clinical practice?. European Psychiatry 25, pages 160.
Crossref
Crossref
Werner Zitterl, Thomas Stompe, Martin Aigner, Karin Zitterl-Eglseer, Kristina Ritter, Georg Zettinig, Kurt Hornik, Susanne Asenbaum, Walter Pirker & Kenneth Thau. (2009) Diencephalic Serotonin Transporter Availability Predicts Both Transporter Occupancy and Treatment Response to Sertraline in Obsessive-Compulsive Checkers. Biological Psychiatry 66:12, pages 1115-1122.
Crossref
Crossref
Antonio Drago & Alessandro Serretti. (2009) Focus on HTR2C: A possible suggestion for genetic studies of complex disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B:5, pages 601-637.
Crossref
Crossref
Susanne Nikolaus, Christina Antke, Konstantin Kley, Markus Beu, Andreas Wirrwar & Hans-Wilhelm Müller. (2009)
Pretreatment with Haloperidol Reduces
123
I-FP-CIT Binding to the Dopamine Transporter in the Rat Striatum: An In Vivo Imaging Study with a Dedicated Small-Animal SPECT Camera
. Journal of Nuclear Medicine 50:7, pages 1147-1152.
Crossref
Crossref
S. Dasari, L. Wang, D.A. Harrison & R.L. Cooper. (2009) Reduced and Misexpression of 5-HT2 Receptors Alters Development, Behavior and CNS Activity in Drosophila melanogaster. International Journal of Zoological Research 5:3, pages 101-114.
Crossref
Crossref
Sarah Grimwood & Paul R. Hartig. (2009) Target site occupancy: Emerging generalizations from clinical and preclinical studies. Pharmacology & Therapeutics 122:3, pages 281-301.
Crossref
Crossref
Siegfried Kasper, Julia Sacher, Nikolas Klein, Nilufar Mossaheb, Trawat Attarbaschi-Steiner, Rupert Lanzenberger, Christoph Spindelegger, Susanne Asenbaum, Alexander Holik & Robert Dudczak. (2009) Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. International Clinical Psychopharmacology 24:3, pages 119-125.
Crossref
Crossref
Martin Fink, Wolfgang Wadsak, Markus Savli, Patrycja Stein, Ulrike Moser, Andreas Hahn, Leonhard-Key Mien, Kurt Kletter, Markus Mitterhauser, Siegfried Kasper & Rupert Lanzenberger. (2009) Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. NeuroImage 45:2, pages 598-605.
Crossref
Crossref
Bettina Bert, Jörg-Peter Voigt, Heike Kusserow, Franz Theuring, André Rex & Heidrun Fink. (2009) Increasing the number of 5-HT1A-receptors in cortex and hippocampus does not induce mnemonic deficits in mice. Pharmacology Biochemistry and Behavior 92:1, pages 76-81.
Crossref
Crossref
Jennifer L. Whistler. 2009. Functional Selectivity of G Protein-Coupled Receptor Ligands. Functional Selectivity of G Protein-Coupled Receptor Ligands
55
69
.
Werner Zitterl, Martin Aigner, Thomas Stompe, Karin Zitterl-Eglseer, Karin Gutierrez-Lobos, Thomas Wenzel, Georg Zettinig, Kurt Hornik, Walter Pirker & Kenneth Thau. (2008) Changes in Thalamus–Hypothalamus Serotonin Transporter Availability during Clomipramine Administration in Patients with Obsessive–Compulsive Disorder. Neuropsychopharmacology 33:13, pages 3126-3134.
Crossref
Crossref
Allison C. Nugent, Alexander Neumeister, David Goldman, Peter Herscovitch, Dennis S. Charney & Wayne C. Drevets. (2008) Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion. NeuroImage 43:4, pages 764-774.
Crossref
Crossref
Herbert Y. Meltzer & Tomiki Sumiyoshi. (2008) Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?. Behavioural Brain Research 195:1, pages 98-102.
Crossref
Crossref
B. Bert, H. Fink, J. Rothe, J. Walstab & H. Bönisch. (2008) Learning and memory in 5-HT1A-receptor mutant mice. Behavioural Brain Research 195:1, pages 78-85.
Crossref
Crossref
Patrycja Stein, Markus Savli, Wolfgang Wadsak, Markus Mitterhauser, Martin Fink, Christoph Spindelegger, Leonhard-Key Mien, Ulrike Moser, Robert Dudczak, Kurt Kletter, Siegfried Kasper & Rupert Lanzenberger. (2008) The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. European Journal of Nuclear Medicine and Molecular Imaging 35:12, pages 2159-2168.
Crossref
Crossref
Tomiki Sumiyoshi, Vera Bubenikova-Valesova, Jiri Horacek & Bettina Bert. (2008) Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. Advances in Therapy 25:10, pages 1037-1056.
Crossref
Crossref
Jun'ichi Semba & Maki Wakuta. (2008) Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: Reversal by co-administration of bupropion. Psychiatry and Clinical Neurosciences 62:4, pages 435-441.
Crossref
Crossref
Antonio Drago, Diana De Ronchi & Alessandro Serretti. (2007) 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. The International Journal of Neuropsychopharmacology 11:05.
Crossref
Crossref
Matthew S. Milak, Alin J. Severance, R. Todd Ogden, Jaya Prabhakaran, J.S. Dileep Kumar, Vattoly J. Majo, J. John Mann & Ramin V. Parsey. (2008)
Modeling Considerations for
11
C-CUMI-101, an Agonist Radiotracer for Imaging Serotonin 1A Receptor In Vivo with PET
. Journal of Nuclear Medicine 49:4, pages 587-596.
Crossref
Crossref
Martin Bauer, Claudia Christina Wagner & Oliver Langer. (2008) Microdosing Studies in Humans. Drugs in R & D 9:2, pages 73-81.
Crossref
Crossref
Tomiki Sumiyoshi, Sohee Park, Karu Jayathilake, Ajanta Roy, Aygun Ertugrul & Herbert Y. Meltzer. (2007) Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: A randomized, double-blind, placebo-controlled study. Schizophrenia Research 95:1-3, pages 158-168.
Crossref
Crossref
Masafumi Yoshimura, Thomas Koenig, Satoshi Irisawa, Toshiaki Isotani, Keizo Yamada, Mitsuru Kikuchi, Gaku Okugawa, Takami Yagyu, Toshihiko Kinoshita, Werner Strik & Thomas Dierks. (2007) A pharmaco-EEG study on antipsychotic drugs in healthy volunteers. Psychopharmacology 191:4, pages 995-1004.
Crossref
Crossref
Jia Hu, Katherine Leitzell, Dan Wang & Michael W. Quick. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
Laurent Bardin, Agnès Auclair, Mark S. Kleven, Eric P.M. Prinssen, Wouter Koek, Adrian Newman-Tancredi & Ronan Depoortère. (2007) Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behavioural Pharmacology 18:2, pages 103-118.
Crossref
Crossref
A. Konstantinidis, W. Hrubos, G. Nirnberger, E. Windhager, M. Lehofer, H. Aschauer & S. Kasper. (2007) Quetiapine in combination with citalopram in patients with unipolar psychotic depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:1, pages 242-247.
Crossref
Crossref
Trawat Attarbaschi, Julia Sacher, Thomas Geiss-Granadia, Nikolas Klein, Nilufar Mossaheb, Rupert Lanzenberger, Susanne Asenbaum, Robert Dudczak, Siegfried Kasper & Johannes Tauscher. (2007) Striatal D2 receptor occupancy in bipolar patients treated with olanzapine. European Neuropsychopharmacology 17:2, pages 102-107.
Crossref
Crossref
N. Klein, J. Sacher, T. Geiss-Granadia, T. Attarbaschi, N. Mossaheb, R. Lanzenberger, C. Pötzi, A. Holik, C. Spindelegger, S. Asenbaum, R. Dudczak, J. Tauscher & S. Kasper. (2006) In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology 188:3, pages 263-272.
Crossref
Crossref
Agnès L Auclair, Mark S Kleven, Joël Besnard, Ronan Depoortère & Adrian Newman-Tancredi. (2006) Actions of Novel Antipsychotic Agents on Apomorphine-Induced PPI Disruption: Influence of Combined Serotonin 5-HT1A Receptor Activation and Dopamine D2 Receptor Blockade. Neuropsychopharmacology 31:9, pages 1900-1909.
Crossref
Crossref
Arturo Zazpe, Inés Artaiz, Ana Innerárity, Elena del Olmo, Elena Castro, Luis Labeaga, Angel Pazos & Aurelio Orjales. (2006) In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. Neuropharmacology 51:1, pages 129-140.
Crossref
Crossref
A. Vicentic, D. Francis, M. Moffett, A. Lakatos, G. Rogge, G.W. Hubert, J. Harley & M.J. Kuhar. (2006) Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brain. Neuroscience 140:1, pages 355-365.
Crossref
Crossref
Julie K. Staley, Gerard Sanacora, Gilles Tamagnan, Paul K. Maciejewski, Robert T. Malison, Robert M. Berman, Meena Vythilingam, Akira Kugaya, Ronald M. Baldwin, John P. Seibyl, Dennis Charney & Robert B. Innis. (2006) Sex Differences in Diencephalon Serotonin Transporter Availability in Major Depression. Biological Psychiatry 59:1, pages 40-47.
Crossref
Crossref
Guadalupe Mengod, M. Teresa Vilaró, Roser Cortés, Juan F. López-Giménez, Andreu Raurich & José M. Palacios. 2006. The Serotonin Receptors. The Serotonin Receptors
319
364
.
Swen Hesse, Ulrich Müller, Thomas Lincke, Henryk Barthel, Thomas Villmann, Matthias C. Angermeyer, Osama Sabri & Katarina Stengler-Wenzke. (2005) Serotonin and dopamine transporter imaging in patients with obsessive–compulsive disorder. Psychiatry Research: Neuroimaging 140:1, pages 63-72.
Crossref
Crossref
Bart A. Ellenbroek. 2005. Dopamine and Glutamate in Psychiatric Disorders. Dopamine and Glutamate in Psychiatric Disorders
153
168
.
H. Lôo, F. Hartmann, M.-F. Poirier, M.-O. Krebs, F. Chauchot, J.-P. Olié & A. Galinowski. (2004) Antidépresseurs. Prédiction de la réponse. EMC - Psychiatrie 1:4, pages 266-272.
Crossref
Crossref
H. Lôo, F. Hartmann, M.-F. Poirier, M.-O. Krebs, F. Chauchot, J.-P. Olié & A. Galinowski. (2004) Antidépresseurs. Prédiction de la réponse. EMC - Psychiatrie 1:4, pages 1-4.
Crossref
Crossref
N. Praschak-Rieder & M. Willeit. 2004. Herbst-/Winterdepression und Lichttherapie. Herbst-/Winterdepression und Lichttherapie
273
286
.
Hans-Peter Volz, Siegfried Kasper & Hans-Jürgen MöllerSiegfried Kasper. 2004. Kasuistische Beiträge zur modernen Pharmakotherapie mit Quetiapin. Kasuistische Beiträge zur modernen Pharmakotherapie mit Quetiapin
368
376
.
Yves Claustre, Danielle De Peretti, Philippe Brun, Christiane Gueudet, Nathalie Allouard, Richard Alonso, Joëlle Lourdelet, André Oblin, Gabrielle Damoiseau, Dominique Françon, Marie-Françoise Suaud-Chagny, Régis Steinberg, Mireille Sevrin, Hans Schoemaker, Pascal George, Philippe Soubrié & Bernard Scatton. (2003) SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile. Neuropsychopharmacology 28:12, pages 2064-2076.
Crossref
Crossref
Brian H Harvey, Bruce S McEwen & Dan J Stein. (2003) Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. Biological Psychiatry 54:10, pages 1105-1117.
Crossref
Crossref
Hélène Audrain, Dirk Bender, Jørgen Scheel‐Krüger, Elsebet Ø. Nielsen, Gunnar M. Olsen, Dan Peters & Paul Cumming. (2003)
Synthesis of the serotonin transporter ligand (±)‐10‐methyl 3‐[6‐nitro‐(2‐quinolinyl)]‐3,10‐diazabicyclo‐[4.3.1]‐decane ([
11
C‐methyl]NS 2495) and first
in vivo
results
. Journal of Labelled Compounds and Radiopharmaceuticals 46:9, pages 873-882.
Crossref
Crossref
S. Kasper & E. Resinger. (2003) Cognitive effects and antipsychotic treatment. Psychoneuroendocrinology 28, pages 27-38.
Crossref
Crossref